Avalo Therapeutics

AVTX

Market cap $288M

18 hedge funds and large institutions have $18.4M invested in Avalo Therapeutics in 2022 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 6 reducing their positions, and 26 closing their positions.

Upgrade to unlock

New

Increased

Maintained

Reduced

Closed

more capital invested

Capital invested by funds: $ → $

more ownership

Funds ownership: →

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less funds holding

Funds holding: →

92% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 26

Holders

Holders Change

Holders Change %

% of All Funds

Holding in Top 10

–

Holding in Top 10 Change

Holding in Top 10 Change %

% of All Funds

New

Increased

Reduced

Closed

Calls

$6K

Puts

–

Net Calls

Net Calls Change

Top Buyers

1		+$52K
2		+$26.9K
3		+$19.6K
4	Northern Trust Chicago, Illinois	+$4K
5	BNP Paribas Financial Markets Paris, France	+$2.38K

Top Sellers

1		-$225K
2		-$170K
3		-$142K
4	Vanguard Group Malvern, Pennsylvania	-$112K
5	Millennium Management New York	-$109K

#	Name	Holding
26	26	–
27	27	–
28	28	–
29	29	–
30	30	–
31	31	–
32	32	–
33	33	–
34	34	–
35	35	–
36	36	–
37	37	–
38	38	–
39	39	–
40	40	–
41	41	–
42	42	–
43	43	–
44	44	–

#	Name	Holding
26	26	–
27	27	–
28	28	–
29	29	–
30	30	–
31	31	–
32	32	–
33	33	–
34	34	–
35	35	–
36	36	–
37	37	–
38	38	–
39	39	–
40	40	–
41	41	–
42	42	–
43	43	–
44	44	–

#	Name	Holding
26	26	–
27	27	–
28	28	–
29	29	–
30	30	–
31	31	–
32	32	–
33	33	–
34	34	–
35	35	–
36	36	–
37	37	–
38	38	–
39	39	–
40	40	–
41	41	–
42	42	–
43	43	–
44	44	–

Avalo Therapeutics AVTX Market cap $288M